Nucleoside transporters: from scavengers to novel therapeutic targets
- 1 August 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 27 (8), 416-425
- https://doi.org/10.1016/j.tips.2006.06.004
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Molecular Pharmacology of Adenosine Transport in Trypanosoma brucei: P1/P2 RevisitedPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2005
- Adenosine contributes to μ-opioid synaptic inhibition in rat substantia gelatinosa in vitroNeuroscience Letters, 2005
- Second-site Suppression of a Nonfunctional Mutation within the Leishmania donovani Inosine-Guanosine TransporterPublished by Elsevier BV ,2005
- Cell entry and export of nucleoside analoguesVirus Research, 2004
- Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep-deprived ratsJournal of Neurochemistry, 2004
- Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1Biochemical Journal, 2004
- Adenosine and sleepSleep Medicine Reviews, 2002
- Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer DrugsJournal of Biological Chemistry, 2001
- Differential Expression of Human Nucleoside Transporters in Normal and Tumor TissueBiochemical and Biophysical Research Communications, 2001
- Pharmacological analysis of the activity of the adenosine uptake inhibitor, dipyridamole, on the sinoatrial and atrioventricular nodes of the guinea‐pigBritish Journal of Pharmacology, 1998